Rezultati - Bijan Etemad-Gilbertson
- Showing 1 - 3 results of 3
-
1
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells od Hao Wang, R. Alejandro Sica, Gurbakhash Kaur, Phillip M. Galbo, Zhixin Jing, Christopher Nishimura, Xiaoxin Ren, Ankit Tanwar, Bijan Etemad-Gilbertson, Britta Will, Deyou Zheng, David Fooksman, Xingxing Zang
Izdano 2024Artigo -
2
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target od Wei Yao, Xiaoxin Ren, Phillip M. Galbo, Scott Moerdler, Hao Wang, R. Alejandro Sica, Bijan Etemad-Gilbertson, Lei Shi, Liqiang Zhu, Xu-Dong Tang, Lin Qi, Mou Peng, Fangxia Guan, Deyou Zheng, Jordan M. Chinai, Xingxing Zang
Izdano 2021Artigo -
3
Long-acting protein drugs for the treatment of ocular diseases od Joy G. Ghosh, Andrew Nguyen, Chad E. Bigelow, Stephen Poor, Yubin Qiu, Nalini Rangaswamy, Richard Ornberg, B. Jackson, Howard Mak, Tucker Ezell, Vania Kenanova, Elisa De La Cruz, Ana Carrión, Bijan Etemad-Gilbertson, Roxana García, Kan Zhu, Vinney George, Jirong Bai, Radhika Sharma-Nahar, Siyuan Shen, Yiqin Wang, Kulandayan K. Subramanian, Elizabeth Fassbender, Michael Maker, Shawn Hanks, Joanna Vrouvlianis, Barrett Leehy, Debby Long, Melissa Prentiss, Viral Kansara, Bruce Jaffee, Thaddeus P. Dryja, Michael Roguska
Izdano 2017Artigo
Iskalna orodja:
Sorodne teme
Biology
Cancer research
Medicine
Immunology
Aflibercept
Bevacizumab
Biochemistry
Bioinformatics
Blockade
Cell biology
Chemistry
Chemotherapy
Computational biology
Dosing
Immune system
Immunotherapy
Internal medicine
Leukemia
Macular degeneration
Myeloid
Myeloid cells
Myeloid leukemia
Ophthalmology
Peptide
Pharmacology
Ranibizumab
Receptor
Retinal
Stem cell
Surgery